Medical Services International Projects
Million Dollar Profit in First Quarter

July 26, 2005

Medical Services International Inc. (OTC: MSITF) projects that in its first fiscal quarter it will exceed $1,000,000 US in profit. Based on existing contracts, current invoices and scheduled deliveries for its VScan products in the first quarter ( July 05 to Sept 05), the Company is projecting that it will report a profit for the first quarter of $1,130,000 US on overall revenue of $2,440,000 US.

As the existing contracts extend through the second quarter and it is anticipated that the Company will obtain additional contracts, it is reasonable to expect that the Company will continue to maintain or slightly exceed its first quarter pace. The time, effort and expense that the Company incurred over the last three years getting its VScan products perfected and approved by regulatory authorities in different countries, as well as setting up distribution networks, is now beginning to pay off.
 
About VScan ™

The VScan™ rapid test kit is a single use, easy to use, test for the screening of HIV 1&2, Hepatitis B&C, Tuberculosis (TB), Dengue Fever and West Nile, Malaria, Syphilis, and Prostate Cancer. The kits cannot be sold in Canada.

For further information contact:
Robert Talbot at 780-430-6363 or
Bill Whitehead, Jr., 416-822-5883

Medical Services International Inc. trades in the United States on the NQB Pinksheets under the symbol "MSITF".